查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1447631

週邊靜脈導管市場-按產品（短PIVC、整合/閉合PIVC）、技術（傳統PIVC、安全PIVC）、管腔（單腔、雙腔、多腔）、最終用途（醫院、門診手術中心）-全球預測, 2024-2032

Peripheral Intravenous Catheters Market-By Product (Short PIVC, Integrated/Closed PIVC), Technology (Conventional PIVC, Safety PIVC), Lumen (Single, Double, Multi-lumen), End-use (Hospitals, Ambulatory Surgical Centers)-Global Forecast, 2024-2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 120 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

由於在醫療領域引入利用導管系統的支援設備，全球週邊靜脈導管市場規模預計 2024 年至 2032 年間CAGR將達到 7.7%。大量創新技術正在補充週邊靜脈導管 (PIVC)，增強其在各種醫療手術中的功能和功效。例如，2023 年 10 月，Linear Health Sciences 的醫療器材 Orchid SRV 安全釋放閥獲得了 FDA 的擴大適應症。此擴充允許 Orchid SRV 與所有 IV 存取方法一起使用。

隨著最佳化導管插入、固定和維護的先進設備的開發，醫療保健提供者正在提高患者的舒適度和安全性，同時確保可靠的靜脈通路。支持技術在醫療領域的不斷滲透也將勾勒出產業的擴張。

整個週邊靜脈導管產業分為產品、技術、管腔、最終用途和區域。

基於技術，從 2024 年到 2032 年，傳統 PIVC 領域的市場佔有率將創下 7.4% 的CAGR。這些導管廣泛用於醫療保健環境中的短期靜脈治療，成為患者護理的關鍵。隨著設計和材料的進步，傳統的 PIVC 提供了改進的插入技術和患者舒適度。它們的多功能性和可靠性使它們對於各種醫療程序至關重要。隨著醫療機構優先考慮病患安全和效率，對傳統 PIVC 領域的需求將持續成長。

2024 年至 2032 年，來自門診手術中心最終用途部分的外周靜脈導管市場收入的複合CAGR將達到8.6%。隨著門診手術中心(ASC) 擴大執行門診手術，對可靠、高效的靜脈通路的需求已變得至關重要。週邊靜脈導管有助於在這些中心的手術和診斷過程中安全、方便地輸送藥物和液體。 ASC 也優先考慮具有成本效益和微創的解決方案，進一步推動產品需求。

2024年至2032年，歐洲週邊靜脈導管產業的CAGR將達到7.1%。歐洲醫院和診所高度重視醫療技術的進步，正在尋求可靠且多功能的周邊靜脈導管來簡化靜脈治療程序。隨著人口老化和醫療基礎設施的不斷發展，對創新導管解決方案的需求日益成長，以提高患者的舒適度並降低併發症的風險。

目錄

第 1 章：方法與範圍

第 2 章：執行摘要

第 3 章：產業洞察

  • 產業生態系統分析
  • 產業影響力
    • 成長動力
      • 慢性病盛行率增加
      • 靜脈注射療法的需求增加
      • 導管技術進步
      • 過渡到微創外科手術
    • 產業陷阱與挑戰
      • 導管相關感染的風險和併發症
  • 成長潛力分析
  • 監管環境
  • 技術景觀
  • 波特的分析
  • PESTEL分析
  • 報銷場景
  • 未來市場趨勢

第 4 章：競爭格局

  • 介紹
  • 公司矩陣分析
  • 公司市佔率分析
  • 競爭定位矩陣
  • 戰略儀表板

第 5 章：市場估計與預測：按產品分類，2018 年 - 2032 年

  • 主要趨勢
  • 短週邊靜脈導管
  • 整合/封閉式 PIVC

第 6 章：市場估計與預測：按技術分類，2018 年 - 2032 年

  • 主要趨勢
  • 傳統週邊靜脈導管
  • 安全週邊靜脈導管

第 7 章：市場估計與預測：按 Lumen，2018 - 2032 年

  • 主要趨勢
  • 單腔
  • 雙腔
  • 多重腔

第 8 章：市場估計與預測：按最終用途，2018 - 2032 年

  • 主要趨勢
  • 醫院
  • 門診手術中心
  • 其他最終用戶

第 9 章：市場估計與預測：按地區分類，2018 年 - 2032 年

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地區
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區

第 10 章：公司簡介

  • AngioDynamics, Inc.
  • Becton, Dickinson and Company
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • ICU Medical, Inc.
  • Lineus Medical
  • MedSource Labs
  • Retractable Technologies Inc.
  • Teleflex Incorporated
  • Terumo Corporation
  • VOGT Medical
  • Vygon
簡介目錄
Product Code: 7984

Global Peripheral Intravenous Catheters Market size is expected to record 7.7% CAGR between 2024 and 2032 due to the introduction of supportive devices utilizing catheter systems in the medical sector. The influx of innovations is complementing peripheral intravenous catheters (PIVC) with enhanced functionality and efficacy in various medical procedures. For instance, in October 2023, a medical device, Orchid SRV safety release valve from Linear Health Sciences received expanded FDA indication. This expansion allowed Orchid SRV to be utilized with all IV access methods.

With the development of advanced devices that optimize catheter insertion, securement, and maintenance, healthcare providers are improving patient comfort and safety while ensuring reliable intravenous access. The rising penetration of supportive technologies in the medical sector will also outline the industry expansion.

The overall peripheral intravenous catheters industry is segmented into product, technology, lumen, end-use, and region.

Based on technology, the market share from the conventional PIVC segment will record 7.4% CAGR from 2024 to 2032. These catheters are widely used in healthcare settings for short-term intravenous therapy, emerging pivotal for patient care. With advancements in design and materials, conventional PIVCs offer improved insertion techniques and patient comfort. Their versatility and reliability make them essential for various medical procedures. With healthcare facilities prioritizing patient safety and efficiency, the demand for conventional PIVC segment will continue to rise.

Peripheral intravenous catheters market revenue from the ambulatory surgical centers end-use segment will register 8.6% CAGR from 2024 to 2032. With ambulatory surgical centers (ASCs) increasingly performing outpatient procedures, the need for reliable and efficient intravenous access has become paramount. PIVCs facilitate the safe and convenient delivery of medications and fluids during surgical and diagnostic procedures in these centers. ASCs are also prioritizing cost-effective and minimally invasive solutions, further driving the product demand.

Europe peripheral intravenous catheters industry will record 7.1% CAGR from 2024 to 2032. With a strong focus on advancing medical technology, European hospitals and clinics are seeking reliable and versatile PIVCs to streamline intravenous therapy procedures. With the presence of an aging population and evolving healthcare infrastructure, there is an increasing need for innovative catheter solutions that offer improved patient comfort and reduced risk of complications.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definition
  • 1.2 Base estimates & calculations
  • 1.3 Data collection
  • 1.4 Forecast calculations
  • 1.5 Data validation
  • 1.6 Data sources
    • 1.6.1 Primary
    • 1.6.2 Secondary
      • 1.6.2.1 Paid sources
      • 1.6.2.2 Unpaid sources

Chapter 2 Executive Summary

  • 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing prevalence of chronic diseases
      • 3.2.1.2 Rise in demand for intravenous therapies
      • 3.2.1.3 Technological advancements in catheters
      • 3.2.1.4 Transitioning to minimally invasive surgical procedures
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Risks and complications of catheter-associated infections
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Technological landscape
  • 3.6 Porter's analysis
    • 3.6.1 Supplier power
    • 3.6.2 Buyer power
    • 3.6.3 Threat of new entrants
    • 3.6.4 Threat of substitutes
    • 3.6.5 Industry rivalry
  • 3.7 PESTEL analysis
  • 3.8 Reimbursement scenario
  • 3.9 Future market trends

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2018 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Short PIVC
  • 5.3 Integrated/closed PIVC

Chapter 6 Market Estimates and Forecast, By Technology, 2018 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Conventional PIVC
  • 6.3 Safety PIVC

Chapter 7 Market Estimates and Forecast, By Lumen, 2018 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Single lumen
  • 7.3 Double lumen
  • 7.4 Multi-lumen

Chapter 8 Market Estimates and Forecast, By End-Use, 2018 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 Hospitals
  • 8.3 Ambulatory surgical centers
  • 8.4 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
    • 9.4.6 Rest of Asia Pacific
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
    • 9.5.4 Rest of Latin America
  • 9.6 Middle East and Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE
    • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

  • 10.1 AngioDynamics, Inc.
  • 10.2 Becton, Dickinson and Company
  • 10.3 B. Braun Melsungen AG
  • 10.4 Boston Scientific Corporation
  • 10.5 ICU Medical, Inc.
  • 10.6 Lineus Medical
  • 10.7 MedSource Labs
  • 10.8 Retractable Technologies Inc.
  • 10.9 Teleflex Incorporated
  • 10.10 Terumo Corporation
  • 10.11 VOGT Medical
  • 10.12 Vygon